1. Anti-neutral glycolipids antibody-positive combined central and peripheral demyelination mimicking encephalomyeloradiculoneuropathy phenotype
- Author
-
Shuta Toru, Tatsuro Mutoh, Kazuyuki Saito, and Sayuri Shima
- Subjects
Male ,0301 basic medicine ,Pathology ,medicine.medical_specialty ,Nervous System Malformations ,03 medical and health sciences ,0302 clinical medicine ,Cerebrospinal fluid ,Glycolipid ,Lag time ,Peripheral demyelination ,medicine ,Humans ,Autoantibodies ,Cerebrospinal Fluid ,biology ,business.industry ,General Medicine ,Middle Aged ,Phenotype ,030104 developmental biology ,Polyradiculoneuropathy, Chronic Inflammatory Demyelinating ,biology.protein ,Surgery ,Neurology (clinical) ,Glycolipids ,Antibody ,business ,Motor neuropathy ,030217 neurology & neurosurgery ,Recovery phase - Abstract
We herein report the first combined central and peripheral demyelination (CCPD) case originally diagnosed as multifocal acquired demyelinating sensory and motor neuropathy followed by CNS impairments with a long lag time (160 days after first attack). The anti-neutral glycolipids antibodies, especially anti-lactosylceramide antibodies but not anti-NF155 antibodies typical for CCPD were detected in the acute phase of sera and cerebrospinal fluid (CSF) and disappeared in the recovery phase. This case strongly illustrated the significance of examining anti-neutral glycolipids antibodies in future anti-NF 155 antibodies-negative CCPD cases.
- Published
- 2018
- Full Text
- View/download PDF